Nuvectis Pharma, Inc. SEC filings NVCT
Nuvectis Pharma, Inc. has 275 filings in SEC EDGAR's recent list, going back to Jul 30, 2021. Its latest annual report, Form 10-K, was filed on Feb 11, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Other events
|
Aug 21, 2026 | Jul 20, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2026 | Aug 4, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 30, 2026 | Jun 29, 2026 |
| 8-K |
Current report
Other events
|
Jun 29, 2026 | Jun 29, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 23, 2026 | Jun 22, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Results of operations
|
May 5, 2026 | May 5, 2026 |
| 8-K |
Current report
Results of operations
|
Feb 11, 2026 | Feb 11, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2025 | Nov 4, 2025 |
| 8-K |
Current report
Officer or director change
|
Sep 25, 2025 | Sep 22, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2025 | Aug 5, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2025 | Jun 12, 2025 |
| 8-K |
Current report
Other events
|
May 9, 2025 | May 9, 2025 |
| 8-K |
Current report
Results of operations
|
May 6, 2025 | May 6, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 25, 2025 | Feb 25, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Feb 6, 2025 | Feb 5, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2024 | Nov 5, 2024 |
| 8-K |
Current report
Other events
|
Aug 29, 2024 | Aug 29, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2024 | Jun 13, 2024 |
| 8-K |
Current report
Results of operations
|
May 7, 2024 | May 7, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 5, 2024 | Mar 5, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2023 | Nov 8, 2023 |
| 8-K |
Current report
Other events
|
Sep 12, 2023 | Sep 12, 2023 |
| 8-K |
Current report
Other events
|
Aug 17, 2023 | Aug 17, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2023 | Aug 9, 2023 |
| 8-K |
Current report
Results of operations
|
Jul 3, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 16, 2023 | Jun 16, 2023 |
| 8-K |
Current report
Results of operations
|
May 15, 2023 | May 15, 2023 |
| 8-K |
Current report
Results of operations
|
May 10, 2023 | May 10, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 7, 2023 | Mar 7, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2022 | Nov 8, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2022 | Aug 5, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jul 29, 2022 | Jul 27, 2022 |
| 8-K |
Current report
Results of operations
|
May 11, 2022 | May 10, 2022 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Mar 22, 2022 | Mar 21, 2022 |
| 8-K |
Current report
Material agreement, Bylaw or fiscal year change
|
Feb 4, 2022 | Feb 4, 2022 |
Showing 38 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NVCT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Fort Lee, NJ
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1875558
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.